Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-17-001693
Filing Date
2017-08-10
Accepted
2017-08-10 16:02:25
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q invobioscience10q063017.htm 10-Q 419045
2 EX-31.1 ex31-1.htm EX-31.1 13990
3 EX-31.2 ex31-2.htm EX-31.2 13936
4 EX-32 ex32.htm EX-32 13537
  Complete submission text file 0001185185-17-001693.txt   2056997

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ivob-20170630.xml EX-101.INS 258911
6 XBRL TAXONOMY EXTENSION SCHEMA ivob-20170630.xsd EX-101.SCH 27572
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ivob-20170630_cal.xml EX-101.CAL 28188
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ivob-20170630_def.xml EX-101.DEF 128864
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivob-20170630_lab.xml EX-101.LAB 160102
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivob-20170630_pre.xml EX-101.PRE 130933
Mailing Address 407R MYSTIC AVENUE SUITE 34C MEDFORD MA 02155
Business Address 407R MYSTIC AVENUE SUITE 34C MEDFORD MA 02155 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

EIN.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-147330 | Film No.: 171021444
SIC: 3841 Surgical & Medical Instruments & Apparatus